While individual profibrotic markers such as FGF-23 or IGFBPs have been previously studied in heart failure, their combined assessment in ATTR-CA and the identification of specific cluster-based phenotypes have not, to our knowledge, been reported yet. This evidence concerns the gene FGF23 and heart failure.